Tyrosine Kinase Inhibitors  >>  Phase 2


12345678910»
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 01224364860728496108120
            
            
             
Hiltonol (poly-ICLC) / Oncovir           
          
            
             
cixutumumab (IMC A12) / Eli Lilly           
          
            
             
Tepmetko (tepotinib) / EMD Serono           
          
            
             
Mobista (CDX-301) / Celldex           
          
            
             
seribantumab (MM-121) / Elevation Oncology           
          
            
             
thrombospondin-1 mimetic (ABT-510) / AbbVie           
          
            
             
bemcentinib (BGB324) / BerGenBio           
          
            
             
cabiralizumab (BMS-986227) / Ono Pharma, BMS           
          
            
             
mivavotinib (CB-659) / Calithera           
          
            
             
simtuzumab (GS 6624) / Gilead           
          
            
             
aldafermin (NGM282) / NGM Biopharma           
          
            
             
ifebemtinib (IN10018) / InxMed           
          
            
             
pimurutamab (HLX07) / Fosun Pharma           
          
            
             
sEphB4-HSA / VasGene, National Cancer Institute           
          
            
             
Oratrope (ibutamoren) / Merck (MSD), Lumos Pharma           
          
            
             
edralbrutinib (TG-1701) / TG Therap           
          
            
             
pegbelfermin (BMS-986036) / BMS           
          
            
             
NN9500 / Novo Nordisk           
          
            
             
SCT200 / Sinocelltech           
          
            
             
foretinib (GSK1363089) / Exelixis           
          
            
             
merestinib (LY2801653) / Eli Lilly           
          
            
             
pegcantratinib (SNA-120) / Sienna           
          
            
             
rovadicitinib (TQ05105) / Sino Biopharm           
          
            
             
BI 836880 / Boehringer Ingelheim           
          
            
             
ETBX-021 / ImmunityBio           
          
            
             
HER-2/neu peptide vaccine / National Cancer Institute - Bethesda           
          
            
             
Hocena (antroquinonol) / Golden Biotechnology           
          
            
             
barzolvolimab (CDX-0159) / Celldex           
          
            
             
branebrutinib (BMS-986195) / BMS           
          
            
             
briquilimab (JSP191) / Jasper Therap           
          
            
             
AMB-05X / AmMax           
          
            
             
Adagio (insulin) / Aerami Therap, Hikma           
          
            
             
M7583 / EMD Serono, Telios Pharma           
          
            
             
Max-40279 / Maxinovel           
          
            
             
VEGFR1-1084 / Tokyo Medical University           
          
            
             
Velexbru (tirabrutinib) / Ono Pharma, Gilead           
          
            
             
ascrinvacumab (GT90001) / Kintor Pharma           
          
            
             
emavusertib (CA-4948) / Curis, Dr. Reddy’s           
          
            
             
taletrectinib (AB-106) / Baoyuan Biopharma, Innovent Biologics           
          
            
             
BMS690514 / BMS           
          
            
             
ENMD-2076 / CASI           
          
            
             
GLPG3667 / Galapagos, Gilead           
          
            
             
edicotinib (PRV-6527) / Sanofi           
          
            
             
golidocitinib (DZD4205) / Dizal Pharma           
          
            
             
golvatinib (E7050) / Eisai           
          
            
             
gusacitinib (ASN002) / Formation Bio           
          
            
             
imifoplatin (PT-112) / Promontory Therap           
          
            
             
lacnotuzumab (MCS110) / Novartis           
          
            
             
lanraplenib (GS-9876) / Gilead, Galapagos, Kronos Bio           
          
            
             
olinvacimab (TTAC-0001) / PharmAbcine           
          
            
            


12345678910»